Sensei Biotherapeutics Inc
SNSE
Market Cap$10.15M
Close$
$0.24
97.2% downside
Current Fair Value
97.2% downsideOvervalued by 97.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.15 Million |
|---|---|
| Enterprise Value | $152,988.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.2 |
| Beta | 0.26 |
| Outstanding Shares | 1,260,867,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -378.32 |
|---|---|
| PEG | 1224.81 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 16.73 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sensei Biotherapeutics Inc
31 employeesSensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a p...